Search for: "PROFESSIONAL DRUG COMPANY, INC." Results 361 - 380 of 715
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Jul 2020, 9:26 am by luiza
(FTC) Huu Tieu, 58, of Porterville, California, president and CEO of Golden Sunrise Pharmaceutical Inc. and Golden Sunrise Nutraceutical Inc., was arrested after a 5-count grand jury indictment was returned, charging him with mail fraud and introducing a misbranded drug into interstate commerce with the intent to defraud. [read post]
7 Jan 2009, 10:09 am
Food and Drug Administration announced a Class I recall of lot no. [read post]
11 Jul 2012, 6:09 am
Zambri, founding member and senior partner Reuters (7/11, Simpson) reports that Atrium Innovations Inc.'s Sedona Labs unit is recalling its iFlora 4-Kids Powder, sold by healthcare professionals, and its iFlora Kids Multi-Probiotic, sold online and in US health food stores, due to possible contamination of a galactooligosaccharide component with salmonella. [read post]
11 Oct 2016, 5:13 am
  This long running saga concerns the thorny intersection of patent rights and antitrust claims, and now - an added attraction in the form of the government's role in providing prescribing guidance to healthcare professionals, and making changes to the NHS drugs tariff for reimbursement. [read post]
4 May 2015, 4:00 am by Administrator
This is the surprising conclusion that emerges from last week’s Supreme Court of Canada decision dismissing a proposed securities class action against Montreal-based pharmaceutical company Theratechnologies Inc. [read post]
17 Sep 2020, 4:55 am by Bob Ambrogi
A spokesperson said the company is currently rethinking its pricing for smaller firms to make Compose more accessible. [read post]
17 Jul 2012, 6:22 pm by FDABlog HPM
Justice, who will be 92 when he can once again provide services to drug companies, essentially got a lifetime debarment? [read post]
15 May 2020, 2:52 pm by luiza
The SEC charged two companies and a CEO with fraud: Applied BioSciences and Turbo Global Partners, Inc., and its CEO Robert W. [read post]
1 Jan 2019, 5:10 pm by Ben Vernia
  This year, pharmaceutical company United Therapeutics Corporation, a seller of pulmonary arterial hypertension (PAH) drugs, paid $210 million to resolve allegations that it used a foundation as an illegal conduit to pay the co-pay obligations of thousands of Medicare patients taking its PAH drugs. [read post]